1
Plasmid 11619: pLB
  • None

  • GFP

  • C terminal on backbone

  • pLL3.7
    (Search Vector Database)

  • N/A

  • Mammalian Expression, Lentiviral, RNAi, Cre/Lox

  • 8500

  • HpaI

  • No

  • XhoI

  • No

  • mU6-F List of Sequencing Primers

  • Ampicillin

  • DH5alpha

  • 37

  • High Copy

  • View sequences (2)
  • View map

  • Stephan Kissler

  • MTA

Comments: 

pLB is a modification of pLL3.7. Two genetic elements known to prevent epigenetic silencing were added. A fragment of one antirepressor element (#40) was cloned upstream of the U6 promoter and a scaffold-attached region (SAR) was cloned downstream of GFP.

Please see author's map for more detailed information.

Note: A single base pair deletion at position 11 of the U6 promoter in this plasmid does not impair the efficacy of this reagent.
There is also a base pair insertion upstream of the promoter. The depositing lab has no indication that it functionally impairs pLB.

Addgene has sequenced a portion of this plasmid for verification. Click here for the sequencing result.

Article: In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes. Kissler et al (Nat Genet. 2006 Apr . 38(4):479-83. PubMed)

Please acknowledge the principal investigator and cite this article if you use this plasmid in a publication. Also, please include the text "Addgene plasmid 11619" in your Materials and Methods section.

Price: $65.00

Available to academic and non-profits only